These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 25583153

  • 1. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
    Zeidan-Shwiri T, Yang Y, Lashevsky I, Kadmon E, Kagal D, Dick A, Laish Farkash A, Paul G, Gao D, Shurrab M, Newman D, Wright G, Crystal E.
    Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
    [Abstract] [Full Text] [Related]

  • 2. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA, Reiber JH, Zeppenfeld K, Lamb HJ, de Roos A, Schalij MJ, Bax JJ.
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [Abstract] [Full Text] [Related]

  • 3. Myocardial scar characteristics based on cardiac magnetic resonance imaging is associated with ventricular tachyarrhythmia in patients with ischemic cardiomyopathy.
    Demirel F, Adiyaman A, Timmer JR, Dambrink JH, Kok M, Boeve WJ, Elvan A.
    Int J Cardiol; 2014 Dec 15; 177(2):392-9. PubMed ID: 25440471
    [Abstract] [Full Text] [Related]

  • 4. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.
    Alexandre J, Saloux E, Lebon A, Dugué AE, Lemaitre A, Roule V, Labombarda F, Champ-Rigot L, Gomes S, Pellissier A, Scanu P, Milliez P.
    Europace; 2014 Feb 15; 16(2):220-6. PubMed ID: 24186956
    [Abstract] [Full Text] [Related]

  • 5. Myocardial tissue characterization by cardiac magnetic resonance imaging using T1 mapping predicts ventricular arrhythmia in ischemic and non-ischemic cardiomyopathy patients with implantable cardioverter-defibrillators.
    Chen Z, Sohal M, Voigt T, Sammut E, Tobon-Gomez C, Child N, Jackson T, Shetty A, Bostock J, Cooklin M, O'Neill M, Wright M, Murgatroyd F, Gill J, Carr-White G, Chiribiri A, Schaeffter T, Razavi R, Rinaldi CA.
    Heart Rhythm; 2015 Apr 15; 12(4):792-801. PubMed ID: 25533585
    [Abstract] [Full Text] [Related]

  • 6. Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up.
    Bernhardt P, Stiller S, Kottmair E, Binner L, Spiess J, Grossmann G, Rasche V, Walcher D, Hombach V.
    Int J Cardiovasc Imaging; 2011 Jul 15; 27(6):893-900. PubMed ID: 20957518
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R, Chaudhry U, van der Pals J, Engblom H, Arheden H, Heiberg E, Wu KC, Borgquist R, Carlsson M.
    Circ Cardiovasc Imaging; 2017 Sep 15; 10(9):. PubMed ID: 28838961
    [Abstract] [Full Text] [Related]

  • 8. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death.
    Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, Marbán E, Lima JA, Tomaselli GF, Weiss RG.
    Circ Cardiovasc Imaging; 2012 Mar 15; 5(2):178-86. PubMed ID: 22267750
    [Abstract] [Full Text] [Related]

  • 9. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
    Fernández-Armenta J, Berruezo A, Mont L, Sitges M, Andreu D, Silva E, Ortiz-Pérez JT, Tolosana JM, de Caralt TM, Perea RJ, Calvo N, Trucco E, Borràs R, Matas M, Brugada J.
    Europace; 2012 Nov 15; 14(11):1578-86. PubMed ID: 22562658
    [Abstract] [Full Text] [Related]

  • 10. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis.
    Strauss DG, Selvester RH, Lima JA, Arheden H, Miller JM, Gerstenblith G, Marbán E, Weiss RG, Tomaselli GF, Wagner GS, Wu KC.
    Circ Arrhythm Electrophysiol; 2008 Dec 15; 1(5):327-36. PubMed ID: 19808427
    [Abstract] [Full Text] [Related]

  • 11. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR, Everaerts K, van der Geest RJ, Hazebroek MR, Siebelink HM, Pison LA, Schalij MJ, Bekkers SC, Heymans S, Zeppenfeld K.
    Heart Rhythm; 2015 Oct 15; 12(10):2106-14. PubMed ID: 26004942
    [Abstract] [Full Text] [Related]

  • 12. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients.
    Zhang Y, Guallar E, Weiss RG, Stillabower M, Gerstenblith G, Tomaselli GF, Wu KC.
    Heart Rhythm; 2016 Aug 15; 13(8):1661-6. PubMed ID: 27108939
    [Abstract] [Full Text] [Related]

  • 13. Characteristic of fibrotic myocardial lesions associated with life-threatening ventricular tachyarrhythmias in patients with ischemic and non-ischemic cardiomyopathies.
    Shlevkov NB, Zhambeev AA, Gasparyan AZ, Shitov VN, Stukalova OV.
    Ter Arkh; 2018 Sep 20; 90(9):42-47. PubMed ID: 30701734
    [Abstract] [Full Text] [Related]

  • 14. Mean entropy predicts implantable cardioverter-defibrillator therapy using cardiac magnetic resonance texture analysis of scar heterogeneity.
    Gould J, Porter B, Claridge S, Chen Z, Sieniewicz BJ, Sidhu BS, Niederer S, Bishop MJ, Murgatroyd F, Ganeshan B, Carr-White G, Razavi R, Chiribiri A, Rinaldi CA.
    Heart Rhythm; 2019 Aug 20; 16(8):1242-1250. PubMed ID: 30849532
    [Abstract] [Full Text] [Related]

  • 15. Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention.
    Sánchez-Somonte P, Quinto L, Garre P, Zaraket F, Alarcón F, Borràs R, Caixal G, Vázquez S, Prat S, Ortiz-Perez JT, Perea RJ, Guasch E, Tolosana JM, Berruezo A, Arbelo E, Sitges M, Mont L, Roca-Luque I.
    Heart Rhythm; 2021 Aug 20; 18(8):1336-1343. PubMed ID: 33892202
    [Abstract] [Full Text] [Related]

  • 16. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012 Aug 20; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 17. Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy.
    Tülümen E, Rudic B, Ringlage H, Hohneck A, Röger S, Liebe V, Kuschyk J, Overhoff D, Budjan J, Akin I, Borggrefe M, Papavassiliu T.
    Heart Rhythm; 2021 Jun 20; 18(6):954-961. PubMed ID: 33515714
    [Abstract] [Full Text] [Related]

  • 18. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR.
    Boyé P, Abdel-Aty H, Zacharzowsky U, Bohl S, Schwenke C, van der Geest RJ, Dietz R, Schirdewan A, Schulz-Menger J.
    JACC Cardiovasc Imaging; 2011 Aug 20; 4(8):871-9. PubMed ID: 21835379
    [Abstract] [Full Text] [Related]

  • 19. Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE-CMR.
    van der Lingen ACJ, Becker MAJ, Kemme MJB, Rijnierse MT, Spoormans EM, Timmer SAJ, van Rossum AC, van Halm VP, Germans T, Allaart CP.
    J Am Heart Assoc; 2021 Apr 20; 10(8):e019101. PubMed ID: 33821672
    [Abstract] [Full Text] [Related]

  • 20. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P, Yee R, Gula L, Krahn AD, Skanes A, Leong-Sit P, Klein GJ, Stirrat J, Fine N, Pallaveshi L, Wisenberg G, Thompson TR, Prato F, Drangova M, White JA.
    Circ Cardiovasc Imaging; 2012 Jul 20; 5(4):448-56. PubMed ID: 22572740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.